reference/29576598

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29576598

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	3420
issn	1528-0020 0006-4971
issueIdentifier	12
pageRange	3409-3420
publicationName	Blood
startingPage	3409
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a0d07cfe2277993e9cdb73248f10164b
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8dd135bb127ab566c1e0894a51d6c578
bibliographicCitation	Warsch W, Kollmann K, Eckelhart E, Fajmann S, Cerny-Reiterer S, Hölbl A, Gleixner KV, Dworzak M, Mayerhofer M, Hoermann G, Herrmann H, Sillaber C, Egger G, Valent P, Moriggl R, Sexl V. High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia. Blood. 2011 Mar 24;117(12):3409–20. doi: 10.1182/blood-2009-10-248211. PMID: 21220747.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3462807f3aaf1563ec06933cc57421e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e18ea6824aec98d54ab0f7f7a517190 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2489-155X http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9363-0412 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c996c229ee6d52f534677239e9bf40bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_596d19c58115d9187afd41aa43b65062 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be3aab703a4061c9feb42b8994e47597 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_406337fd4776d8de48fc3dfb73c6ec6f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a62014f1b5a956edb44ff1634e3a0e0e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebed273f3dd3048b3116e0d81c7083c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0bcbe84062623a21460870c439ff3c59 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0918-9463 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d21fe2311d9262e2099080892219e7f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d6b76d871281d20081b124f2f3eccaa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e186c1357c03de546803ef654fa37777 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19fbcb92eefa1b0036cc8dc790e28f9f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af13b0e04f2b2f3729e3cca8f2a01d0d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_deb73b15d651e98efe59eb85ed181e67 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5095-4641 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a5d9464adaec915f3aad35605fdb523
date	2011-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1182/blood-2009-10-248211 https://pubmed.ncbi.nlm.nih.gov/21220747
isPartOf	https://portal.issn.org/resource/ISSN/1528-0020 https://portal.issn.org/resource/ISSN/0006-4971 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1243
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia
discusses	http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0420149 http://id.nlm.nih.gov/mesh/M0016884 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0002327
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D019008Q000235 http://id.nlm.nih.gov/mesh/D015464Q000235 http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D010879Q000627 http://id.nlm.nih.gov/mesh/D050799Q000502 http://id.nlm.nih.gov/mesh/D015464Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D015854Q000235 http://id.nlm.nih.gov/mesh/D008822 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D015464Q000473 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D015854Q000502 http://id.nlm.nih.gov/mesh/D002478 http://id.nlm.nih.gov/mesh/D015972Q000502 http://id.nlm.nih.gov/mesh/D050799Q000235 http://id.nlm.nih.gov/mesh/D016513 http://id.nlm.nih.gov/mesh/D016688 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D000068877 http://id.nlm.nih.gov/mesh/D001549 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D015464Q000175 http://id.nlm.nih.gov/mesh/D017211
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3657 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_54e32599939667ce8030f6c1725ceac0 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472a53b1a4ec3818b8392773f5523355 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a5b54f0f79fca3f7edae711252821b60 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644241 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6057 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6776 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129520807 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247851103

Total number of triples: 91.